Lipoxamycin

• CAT Number: M063815
• CAS Number: 11075-87-9
• Molecular Formula: C38H74N4O14S
• Molecular Weight: 843.08
• Purity: ≥95%
• Synonyms: Lipoxamycin
• Target: Fungal
• Storage: Store at +4C
• IUPAC Name: (2S)-2-amino-N,3-dihydroxy-N-(14-methyl-3,10-dioxopentadecyl)propanamide;sulfuric acid
• InChI: InChI=1S/2C19H36N2O5.H2O4S/c2*1-15(2)8-7-11-16(23)9-5-3-4-6-10-17(24)12-13-21(26)19(25)18(20)14-22;1-5(2,3)4/h2*15,18,22,26H,3-14,20H2,1-2H3;(H2,1,2,3,4)/t2*18-;/m00./s1
• InChIKey: LQVOFMWEPHCSIY-IJBYHFJWSA-N
• SMILES: CC(C)CCCC(=O)CCCCCCC(=O)CCN(C(=O)[C@H](CO)N)O.CC(C)CCCC(=O)CCCCCCC(=O)CCN(C(=O)[C@H](CO)N)O.OS(=O)(=O)O

Lipoxamycin（Cat No.:M063815）is a potent bioactive compound known for its inhibitory effects on the 5-lipoxygenase (5-LOX) enzyme, a key enzyme involved in the biosynthesis of pro-inflammatory leukotrienes. By selectively targeting 5-LOX, Lipoxamycin plays a significant role in modulating inflammatory responses, making it a promising candidate for therapeutic applications in diseases characterized by chronic inflammation, such as asthma, rheumatoid arthritis, and inflammatory bowel disease. Its potential as a lead compound for the development of novel anti-inflammatory drugs highlights its relevance in biomedical research and drug discovery.